COPD_A_215859 2959..2970
暂无分享,去创建一个
N. Zidouni | S. Amr | E. Malvolti | Wael | H. Gunen | N. Kokturk | A. Alzaabi | Mousa | Alev Gurgun | Abuharbid | Albanna | Khadadah | Medhat Soliman | Richard | van Zyl-Smit
[1] Evaluating the impact of morning symptoms in COPD using the Capacity of Daily Living during the Morning (CDLM) questionnaire , 2018, International journal of chronic obstructive pulmonary disease.
[2] Kun Li,et al. Daily Symptom Variability in Patients With Stable COPD: A Narrative Review , 2018, Western journal of nursing research.
[3] L. Tariq,et al. Adherence to COPD treatment in Turkey and Saudi Arabia: results of the ADCARE study , 2018, International journal of chronic obstructive pulmonary disease.
[4] M. Miravitlles,et al. Characteristics of COPD patients according to GOLD classification and clinical phenotypes in the Russian Federation: the SUPPORT trial , 2017, International journal of chronic obstructive pulmonary disease.
[5] T. Greulich,et al. Prevalence of comorbidities in COPD patients by disease severity in a German population. , 2017, Respiratory medicine.
[6] M. Miravitlles,et al. Understanding the impact of symptoms on the burden of COPD , 2017, Respiratory Research.
[7] N. Scichilone,et al. Symptom variability and control in COPD: Advantages of dual bronchodilation therapy. , 2017, Respiratory medicine.
[8] N. Chavannes,et al. Morning symptoms in COPD: a treatable yet often overlooked factor , 2017, Expert review of respiratory medicine.
[9] J. Cardoso,et al. Understanding COPD: A vision on phenotypes, comorbidities and treatment approach. , 2016, Revista portuguesa de pneumologia.
[10] A. McIvor,et al. GOLD Stage and Treatment in COPD: A 500 Patient Point Prevalence Study. , 2016, Chronic obstructive pulmonary diseases.
[11] U. Yılmaz,et al. Categorization of COPD patients in Turkey via GOLD 2013 strategy document: ALPHABET study , 2015, International journal of chronic obstructive pulmonary disease.
[12] Anand A. Dalal,et al. Application of the new GOLD COPD staging system to a US primary care cohort, with comparison to physician and patient impressions of severity , 2015, International journal of chronic obstructive pulmonary disease.
[13] M. Çakır,et al. Do females behave differently in COPD exacerbation? , 2015, International journal of chronic obstructive pulmonary disease.
[14] D. Price,et al. Comorbidities of patients in tiotropium clinical trials: comparison with observational studies of patients with chronic obstructive pulmonary disease , 2015, International journal of chronic obstructive pulmonary disease.
[15] J. Croft,et al. Smoking Prevalence and Cessation Characteristics among U.S. Adults With and Without COPD: Findings from the 2011 Behavioral Risk Factor Surveillance System , 2014, COPD.
[16] D. Price,et al. Observational study to characterise 24-hour COPD symptoms and their relationship with patient-reported outcomes: results from the ASSESS study , 2014, Respiratory Research.
[17] N. Chavannes,et al. COPD symptoms in the morning: impact, evaluation and management , 2013, Respiratory Research.
[18] J. López-Campos,et al. Symptom variability in COPD: a narrative review , 2013, International journal of chronic obstructive pulmonary disease.
[19] F. Martinez,et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. , 2007, American journal of respiratory and critical care medicine.
[20] D. Hyun,et al. Patient's Perception of Symptoms Related to Morning Activity in Chronic Obstructive Pulmonary Disease: The SYMBOL Study , 2012, The Korean journal of internal medicine.
[21] Dirkje S Postma,et al. Prediction and course of symptoms and lung function around an exacerbation in chronic obstructive pulmonary disease , 2012, Respiratory Research.
[22] M Cazzola,et al. Symptom variability in patients with severe COPD: a pan-European cross-sectional study , 2010, European Respiratory Journal.
[23] T. Welte,et al. Development and validation of the Capacity of Daily Living during the Morning questionnaire and the Global Chest Symptoms Questionnaire in COPD , 2009, European Respiratory Journal.
[24] M. Decramer,et al. Effect of tiotropium on outcomes in patients with moderate chronic obstructive pulmonary disease (UPLIFT): a prespecified subgroup analysis of a randomised controlled trial , 2009, The Lancet.
[25] J A Anderson,et al. Adherence to inhaled therapy, mortality and hospital admission in COPD , 2009, Thorax.
[26] M. Partridge,et al. Patient insight into the impact of chronic obstructive pulmonary disease in the morning: an internet survey , 2009, Current medical research and opinion.
[27] W. MacNee,et al. Evaluation of COPD Longitudinally to Identify Predictive Surrogate End-points (ECLIPSE) , 2008, European Respiratory Journal.
[28] J. Wedzicha,et al. COPD exacerbations: definitions and classifications , 2003, European Respiratory Journal.